Appendix E - National Coverage Determinations Manual / Home_Use_of_Oxygen_in_Approved_Clinical_Trials_240.2.1

Why This Topic Matters

Coverage rules for home oxygen can affect whether services are payable when furnished in a clinical trial setting. Understanding the policy scope helps organizations align documentation, trial enrollment, and billing workflows with Medicare requirements.

Article Sections

1. A. General

   Provides background on supplemental oxygen therapy, the clinical context for its use, and the general evidence-based basis for policy development.

2. B. Nationally Covered Indications

   Describes the covered setting and patient/trial participation circumstances associated with this Medicare policy, along with the effective date of coverage.

3. C. Nationally Non-Covered Indications

   Identifies the non-covered portion of the policy framework.

4. D. Other

   Explains how this policy relates to other national coverage determinations for home oxygen outside approved clinical trials and notes the review history.